Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Wittig

Showing results (61-70 of 89) with videos related to

Pageof 9
Sort By:
Tissue Antigens|July 8, 2000
Cytomegalovirus-infected neuroblastoma cells exhibit augmented invasiveness mediated by beta1alpha5 integrin (VLA-5)M Scholz, R A Blaheta, B Wittig, et al.
Journal of Molecular Medicine (Berlin, Germany)|August 4, 2001
Priming of immune responses to hepatitis B surface antigen with minimal DNA expression constructs modified with a nuclear localization signal peptideR Schirmbeck, S A König-Merediz, P Riedl, et al.
Cytokine|June 14, 2000
Comparison of non-viral transfection methods in melanoma cell primary culturesB Micka, B Trojaneck, S Niemitz, et al.
Annals of Hematology|December 19, 1998
Regulation and possible function of axl expression in immature human mast cellsI Heide, A C Sokoll, B M Henz, et al.
Nucleic Acids Research|November 1, 2000
Cloning of an interferon regulatory factor 2 isoform with different regulatory abilityS A Koenig Merediz, M Schmidt, G J Hoppe, et al.
The Clinical Investigator|May 1, 1994
Enormous hemangiosarcoma of the heartW Herr, A Schwarting, B Wittig, et al.
Gastroenterology|September 29, 1999
Protection of trinitrobenzene sulfonic acid-induced colitis by an interleukin 2-IgG2b fusion protein in miceA Stallmach, B Wittig, T Giese, et al.
British Journal of Cancer|July 17, 1998
Vaccination with IL-7 gene-modified autologous melanoma cells can enhance the anti-melanoma lytic activity in peripheral blood of patients with a good clinical performance status: a clinical phase I studyP Möller, Y Sun, T Dorbic, et al.
Gene Therapy|April 16, 1998
Increase of proliferation rate and enhancement of antitumor cytotoxicity of expanded human CD3+ CD56+ immunologic effector cells by receptor-mediated transfection with the interleukin-7 geneS Finke, B Trojaneck, P Lefterova, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2000
Expression of interferon regulatory factor 4 in chronic myeloid leukemia: correlation with response to interferon alfa therapyM Schmidt, A Hochhaus, S A König-Merediz, et al.
Pageof 9

Showing results (61-70 of 89) with videos related to

Sort By:
Pageof 9
Tissue Antigens|July 8, 2000
Cytomegalovirus-infected neuroblastoma cells exhibit augmented invasiveness mediated by beta1alpha5 integrin (VLA-5)M Scholz, R A Blaheta, B Wittig, et al.
Journal of Molecular Medicine (Berlin, Germany)|August 4, 2001
Priming of immune responses to hepatitis B surface antigen with minimal DNA expression constructs modified with a nuclear localization signal peptideR Schirmbeck, S A König-Merediz, P Riedl, et al.
Cytokine|June 14, 2000
Comparison of non-viral transfection methods in melanoma cell primary culturesB Micka, B Trojaneck, S Niemitz, et al.
Annals of Hematology|December 19, 1998
Regulation and possible function of axl expression in immature human mast cellsI Heide, A C Sokoll, B M Henz, et al.
Nucleic Acids Research|November 1, 2000
Cloning of an interferon regulatory factor 2 isoform with different regulatory abilityS A Koenig Merediz, M Schmidt, G J Hoppe, et al.
The Clinical Investigator|May 1, 1994
Enormous hemangiosarcoma of the heartW Herr, A Schwarting, B Wittig, et al.
Gastroenterology|September 29, 1999
Protection of trinitrobenzene sulfonic acid-induced colitis by an interleukin 2-IgG2b fusion protein in miceA Stallmach, B Wittig, T Giese, et al.
British Journal of Cancer|July 17, 1998
Vaccination with IL-7 gene-modified autologous melanoma cells can enhance the anti-melanoma lytic activity in peripheral blood of patients with a good clinical performance status: a clinical phase I studyP Möller, Y Sun, T Dorbic, et al.
Gene Therapy|April 16, 1998
Increase of proliferation rate and enhancement of antitumor cytotoxicity of expanded human CD3+ CD56+ immunologic effector cells by receptor-mediated transfection with the interleukin-7 geneS Finke, B Trojaneck, P Lefterova, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2000
Expression of interferon regulatory factor 4 in chronic myeloid leukemia: correlation with response to interferon alfa therapyM Schmidt, A Hochhaus, S A König-Merediz, et al.
Pageof 9